Tuhura Biosciences Inc (HURA)

Jun 16, 2026

Citizens reiterates TuHURA Biosciences stock rating on AML progress By Investing.com - Investing.com Canada

Jun 16, 2026

Jun 15, 2026

TuHURA Biosciences (NASDAQ:HURA) files IND for TBS-2025 - grafa.com

Jun 15, 2026

Jun 15, 2026

TuHURA files IND for TBS-2025 in blood cancer study - Investing.com

Jun 15, 2026

Jun 15, 2026

TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers - PR Newswire

Jun 15, 2026

Jun 14, 2026

TuHURA Biosciences Q1 2026 Earnings: EPS Misses Estimates, Stock Rises Despite Wider Loss - newsline.com

Jun 14, 2026

Jun 12, 2026

HURA Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Stage; Stock Gains 5.29%Margin Expansion Trends - newsline.com

Jun 12, 2026

Jun 11, 2026

TuHURA Biosciences Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Risk Report - newsline.com

Jun 11, 2026

Jun 10, 2026

TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Miss Highlights Pre-Revenue Biotech's Expense Management ChallengesSurprise Factor Analysis - newsline.com

Jun 10, 2026

Jun 09, 2026

TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue PhaseMargin Improvement Report - newsline.com

Jun 09, 2026

Jun 06, 2026

TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Misses Estimates, Stock Slides on Higher Cash Burn and Pre-Revenue StatusRevenue Miss Report - newsline.com

Jun 06, 2026

Jun 05, 2026

HURA News | TUHURA BIOSCIENCES INC (NASDAQ:HURA) - ChartMill

Jun 05, 2026

May 31, 2026

TuHURA Biosciences, Inc. Files Form 8-K with Nasdaq Listing Details and Company Information - Minichart

May 31, 2026

May 29, 2026

TuHURA Biosciences Draws on New $50M Credit Facility - TipRanks

May 29, 2026

May 29, 2026

TuHURA (NASDAQ: HURA) taps $1.7M from $50M revolving loan facility - Stock Titan

May 29, 2026

May 29, 2026

TuHURA Biosciences (HURA) CEO James Bianco gifts 150,000 shares to adult sons - Stock Titan

May 29, 2026

May 26, 2026

HURA: Refining TBS-2025 Development Plan - Yahoo Finance

May 26, 2026

May 25, 2026

TuHURA Biosciences Inc. (HURA) Rises 6.84% as Price Tests Key Resistance LevelTriangle Correction - newsline.com

May 25, 2026

May 23, 2026

TuHURA Biosciences Inc. Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineGuidance vs Actual - newsline.com

May 23, 2026

May 22, 2026

TuHURA Biosciences (HURA) Gains Nearly 7% as Shares Approach Key Resistance at $2.62Synthetic Short - Newser

May 22, 2026

May 18, 2026

Leverage, Covenants and Royalty Drain: Why Tuhura Biosciences’ Parkview Credit Deal Heightens Liquidity and Dilution Risks - The Globe and Mail

May 18, 2026

May 16, 2026

TuHURA Biosciences Secures $50M Credit Facility and Reports Q1 2026 Financial Results, Advancing Phase 3 Immuno-Oncology Programs - Minichart

May 16, 2026

May 15, 2026

TuHURA Biosciences Extends Cash Runway and Advances Pipeline - TipRanks

May 15, 2026

May 15, 2026

TuHURA Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2026

May 15, 2026

TuHURA Biosciences, Inc. 1Q 2026: Revenue $0 Net loss $(7.54M), EPS $(0.13) — 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

TuHURA Biosciences (HURA) adds $50M credit line amid $7.5M loss - Stock Titan

May 15, 2026

May 15, 2026

TuHURA Biosciences (Nasdaq: HURA) secures $50M credit facility and outlines Q1 2026 pipeline milestones - Stock Titan

May 15, 2026

May 15, 2026

TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update - PR Newswire

May 15, 2026

May 13, 2026

TuHURA Biosciences, Inc. (HURA) Eps Diluted (TTM) - Zacks Investment Research

May 13, 2026

May 13, 2026

HURA Stock Chart | TUHURA BIOSCIENCES INC (NASDAQ:HURA) - ChartMill

May 13, 2026

May 12, 2026

TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference - ChartMill

May 12, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 10, 2026

TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 10, 2026

May 09, 2026

Number of shareholders of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView

May 09, 2026

May 08, 2026

HURA Stock Price and Chart — NASDAQ:HURA - TradingView

May 08, 2026

May 08, 2026

Why TuHURA Biosciences (HURA) is trading below its true worth (Trend Weakens) 2026-05-08Beta Neutral Pair - newsline.com

May 08, 2026

May 02, 2026

Tuhura Biosciences, Inc. 2025 Annual Report: Financial Results, Research & Development Expenses, and Key Business Highlights - Minichart

May 02, 2026

May 01, 2026

HURA Should I Buy - Intellectia AI

May 01, 2026

Apr 30, 2026

TuHURA Biosciences (NASDAQ: HURA) updates Kineta merger pro forma loss to $34.6M - Stock Titan

Apr 30, 2026

Apr 30, 2026

TuHURA Biosciences (NASDAQ: HURA) details 2025 loss and cash runway - Stock Titan

Apr 30, 2026

Apr 29, 2026

HURA TuHURA Biosciences Q4 2025 EPS trails estimates by 28.2 percent, shares slip 1.41 percent in today’s trading. - newsline.com

Apr 29, 2026

Apr 27, 2026

Citizens initiates TuHURA Biosciences stock with outperform rating By Investing.com - Investing.com South Africa

Apr 27, 2026

Apr 27, 2026

Citizens initiates TuHURA Biosciences stock with outperform rating - Investing.com

Apr 27, 2026

Apr 25, 2026

TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat

Apr 25, 2026

Apr 24, 2026

TuHURA Biosciences names Amanda Garofalo as clinical operations SVP By Investing.com - Investing.com Nigeria

Apr 24, 2026

Apr 23, 2026

Tuhura Biosciences secures $50 million credit facility, extends cash runway to 2028 - MSN

Apr 23, 2026

Apr 23, 2026

TuHURA Biosciences secures $50M credit facility from affiliate By Investing.com - Investing.com India

Apr 23, 2026

Apr 23, 2026

HURA (TuHURA Biosciences Inc.) posts 28.2 percent negative Q4 2025 EPS surprise, with shares falling 1.35 percent today.Community Risk Signals - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 22, 2026

TuHURA Biosciences secures $50M credit facility from affiliate - Investing.com

Apr 22, 2026

Apr 22, 2026

TuHURA Biosciences Secures $50 Million Credit Facility - TipRanks

Apr 22, 2026

Apr 22, 2026

TuHURA Biosciences (Nasdaq: HURA) adds $50M credit line and IFx-2.0 royalty - Stock Titan

Apr 22, 2026

Apr 22, 2026

TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028 - PR Newswire

Apr 22, 2026

Apr 21, 2026

TuHURA Biosciences Advances Cancer Drug Trials Following 2025 Results - HarianBasis.co

Apr 21, 2026